The task force will be charged with researching the reasons certain shortages are persistent and finding holistic solutions to address the causes of the shortages.
The group, which will expand on the work of a group created by the FDA’s Safety and Innovation Act of 2012, will be led by Keagan Lenihan, the FDA’s associate commissioner for strategic initiatives.
To ensure holistic solutions, the group will tap senior leaders from the FDA, CMS and the Department of Veterans affairs.
More articles on pharmacy:
Packaging concerns force Novartis, Sandoz to recall 12 drugs
Pfizer stock value dips after Trump’s tweet
8 lesser-known facts about Pfizer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.